MSB 1.04% $1.46 mesoblast limited

News Flash: 9 Analysts Think Mesoblast Limited (ASX:MSB) Earnings Are Under Threat, page-70

  1. 30,375 Posts.
    lightbulb Created with Sketch. 1858
    now you're being ridiculous. The science btw is not fixed, it's moving. That's why MSB is at the frontier. Our stem cells are leading the way.

    The problem has been the haphazard way the Trump administration went about the response to Covid19 and the lack of available candidates for the clinical trials. There is science and there's circumstance.

    You are master of misleading oversimplification.




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.